Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization

Age-related macular degeneration (AMD) is the primary cause of blindness in advanced countries. Repeated intravitreal delivery of anti-vascular endothelial growth factor (VEGF) agents has represented an important advancement for the therapy of wet AMD with significative results in terms of blindness...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: Tarallo, Valeria, Iaccarino, Emanuela, Cicatiello, Valeria, Sanna, Riccardo, Ruvo, Menotti, De Falco, Sandro
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7014271/
https://ncbi.nlm.nih.gov/pubmed/31936463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21020410
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi